• Home
  • » 
  • Reports
  • » 
  • Quantum Computing Market in Drug Discove...

Quantum Computing Market

Quantum Computing Market in Drug Discovery, 2023-2035: Distribution by Drug Discovery Service Offered (Target Identification / Validation, Hit Generation / Lead Identification and Lead Optimization), Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Dermatological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Immunological Disorders, Infectious Diseases, Musculoskeletal Disorders, Oncological Disorders, Respiratory Disorders and Others), and Key Geographical Regions (North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa): Industry Trends and Global Forecasts

  • Lowest Price Guaranteed From USD 4,799

  • Published
    February 2023

  • Slides
    178

  • View Count
    10925

  • Buy Now

Example Insights

Please check below for insights

Report Description

Quantum Computing In Drug Discovery: Market Overview

The global quantum computing market in drug discovery is estimated to be USD 411 million in 2022 and is anticipated to grow at a CAGR of 13.6% during the forecast period. The early stages of research related to drug discovery, including the identification of a relevant biological target and a viable lead compound, play an important role in the overall success of a drug candidate in preclinical and clinical studies. The process of drug development, beginning from the discovery of a pharmacological lead to its commercial launch, is estimated to take around 10-15 years, involving capital investments in the range of USD 4 billion - USD 10 billion. Over time, the complexities associated with drug discovery have increased, specifically, for large molecules, which are inherently more complex than small molecule drugs. In order to overcome various challenges related to drug discovery, such as rising capital requirements and failure of late-stage programs, several pharmaceutical players are currently exploring the implementation of quantum computing in drug discovery processes. Quantum computing is a process that uses laws of quantum mechanics to solve large and complex problems in a short span as compared to the computer-aided drug discovery. Currently, there are several quantum computing related approaches that are being used in the drug discovery process alone, such as structure-based drug design, fragment-based drug discovery and ligand-based drug discovery. The predictive power of quantum computing has proven to reduce the complexity, cost and time investment in the overall drug discovery procedure by allowing researchers to bypass the random screening of billions of molecules in a short span of time. As a result, the pharmaceutical industry stakeholders have started relying on the companies offering quantum computing software and hardware to support drug discovery. Furthermore, considering the various initiatives being undertaken actively by quantum computing companies, we are led to believe that the opportunity for stakeholders in this niche, upcoming industry is likely to grow at a steady pace in the foreseen future.

The image provides context of quantum computing market. Stakeholders in the biopharmaceutical industry are currently exploring the implementation of quantum computing in drug discovery to expediate the process and cut down the overall R&D capital investment This image provides a list of quantum computing companies. Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery The infographic highlights quantum computing market landscape. Leveraging their expertise, 86% stakeholders offer such services across target discovery / identification, primarily focusing on oncological disorders

Key Market Insights

The Quantum Computing Market in Drug Discovery: Distribution by Drug Discovery Service Offered (Target Identification / Validation, Hit Generation / Lead Identification and Lead Optimization), Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Dermatological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Immunological Disorders, Infectious Diseases, Musculoskeletal Disorders, Oncological Disorders,  Respiratory Disorders and Others), and Key Geographical Regions (North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future potential of quantum computing in drug discovery market. The report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. The report answers many key questions related to this domain.

Quantum Computing Technology is Supporting Drug Discovery

Quantum computing is a rapidly emerging technology that uses quantum mechanism to solve large and complex problems in a short span of time as compared to traditional computers. Quantum computing has created a huge impact on the pharmaceutical industry in a short time period. It has wide applications in the pharmaceutical industry / medicine in areas such as drug discovery, disease analysis and diagnosis. Various industry stakeholders are integrating quantum computing for the discovery and development of drugs. Presently, quantum computing is used for the discovery and development of drugs owing to its capability of screening billions of molecules for specific targets in a short span of time. This procedure reduces the complexity and helps in saving time and cost associated with the drug discovery process. Quantum technology is supporting several steps within drug discovery from target identification to lead optimization.

Owing to the various benefits of quantum computing, such as big data processing and complex molecular modeling for minimizing cost and time investment, the adoption rate of quantum computing in pharmaceutical industry is expected to increase rapidly during the forecast period.

Quantum Computing Market Landscape

The companies supporting drug discovery efforts include both quantum computing software providers and quantum computing hardware providers. Software companies claim to offer services across various types of drug discovery steps. Further, these are focused on different types of therapeutic areas, primarily including oncological disorders, infectious diseases and cardiovascular disorders. Hardware companies primarily offer hardware as a service; some of the players also offer the option of purchasing the hardware directly. 

Quantum Computing Market Trends: Partnerships and Collaborations to Drive the application of Quantum Technology in Drug Discovery?

Currently, various partnerships have been inked for application of quantum computing in drug discovery. Majority of these partnerships are research and development agreements, followed by platform utilization agreements. Drug developers require support from both quantum computing software and hardware developers. In July 2021, Riverlane and Astex Pharmaceuticals announced their collaboration with Rigetti Computing to utilize their quantum systems along with Riverlane’s algorithm expertise to develop molecular models of chemical compounds and study their interaction with proteins in the human body. Another UK based company, Quantinnum, launched its quantum computational chemistry software named InQuanto in 2022. The company collaborated with an undisclosed big pharmaceutical developer for quantifying drug-protein interactions. Collaborations will be inevitable in this market and will put forward quantum computing use cases for the pharmaceutical industry. We expect the quantum computing software and hardware companies to increasingly collaborate with the drug developers to provide a solution to the drug discovery and drug design challenges, driving the market growth during the forecast period.

Recent Development in Quantum Computing Market for Drug Discovery Application

In addition to the partnerships and collaboration between the industry players, a number of academic institutes are collaborating with quantum computing software and hardware companies on projects to accelerate the use of quantum computing in drug discovery and development. Such projects are receiving grants from several non-profit organizations. Currently, more than 170 grants have been awarded to various organizations, primarily focused on quantum computing in drug discovery. Further, it is important to mention that the maximum number of grants have been awarded under type 5 category. In late 2022, a team of researchers at Pennsylvania State University received USD 1.2 million grant from the National Science Foundation to design drugs targeting Ras family for treatment of cancer. In the UK as well, Innovate UK’s Industrial Strategy Challenge Fund provided a GBP 6.85 million grant to SEEQC for development of a full-stack quantum computer for Merck. Riverlane, Oxford Instruments, the University of Oxford, Medicines Discovery Catapult, and members from the Science and Technology Facilities Council, including the UK’s National Quantum Computing Centre are all part of the consortium led by SEEQC which is responsible for the project.

Quantum Computing in Drug Discovery Market Size

As the adoption of quantum computing in drug discovery increases amongst innovators in the pharmaceutical and biopharmaceutical industries, lucrative opportunities are expected to emerge for players offering services for quantum computing in drug discovery. The global quantum computing market, focused on drug discovery is expected to grow at a CAGR of ~14% from 2023 to 2035.

North America Will Continue to be the Driving Force Within the Quantum Computing Market for Drug Discovery

North America currently holds nearly 50% share of the quantum computing market for drug discovery. This region will continue to drive the market growth during the forecast period with an estimated CAGR of 14% from 2023 – 2035. A number of start-ups working on improving the drug discovery process using quantum computing are based in North America and Europe. One such company in the US based quantum computing software developer, Zapata Computing, which was formed as a spin-off from Harvard University in 2017. 

Leading Quantum Computing Companies Supporting Drug Discovery

Examples of service providers engaged in quantum computing market (which have also been captured in this report) include (in alphabetic order) Accenture, Aurora Fine Chemicals, Amazon Web Services, Huawei, IBM, Microsoft, Fujitsu, Xanadu and XtalPi. This market report includes information on all the quantum computing software and hardware companies supporting the application of quantum technology in drug discovery.

Recent Developments in Quantum Computing in Drug Discovery Market

Several recent developments have taken place in the field of quantum computing in drug discovery. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In June 2023, Algorithmiq raised USD 15 million in Series A funding round. 
  • In April 2023, Moderna announced the collaboration with IBM with an aim to explore quantum computing and artificial intelligence to advance and accelerate mRNA research and science. 
  • In March 2023, Cleveland Clinic in collaboration with IBM launched first deployment of an onsite private sector IBM-managed quantum computer in the US for healthcare research.
The image provides a list of quantum computing hardware proviers. More than 30 players, worldwide, claim to offer hardware-as-a-service for quantum computing in drug discovery, and have developed the required expertise in different types of computational approaches This image provides a view on quantum computing hardware providers market distribution. Majority of the quantum computing hardware providers, headquartered in North America, were established before the year 2000; in fact, ~50% of the overall market landscape is catered to by large companies The infographic highlights that the rise in the adoption of quantum computing in the biopharmaceutical industry is anticipated to create profitable business opportunities for both quantum computing software and hardware providers

Scope of the Report

The quantum computing report features an in-depth analysis of various firms / organizations that are engaged in supporting drug discovery, across different segments as defined in the table below:

Report Attribute Details

Forecast Period

2023 – 2035
Base Year 2022

Market Size 2022

$411 million

CAGR

13.6%

Type of Drug Discovery Services Offered

Target Identification / Validation, Hit Generation / Lead Identification, Lead Optimization

Therapeutic Area

Cardiovascular Disorders, CNS Disorders, Dermatological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Immunological Disorders, Infectious Diseases, Musculoskeletal Disorders, Oncological Disorders, Respiratory Disorders, Other Indications

Key Geographical Regions

 North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Middle East and North Africa, Latin America

Key Companies Profiled

Accenture, Amazon Web Services, Atos, Fujitsu, Huawei, IBM, Microsoft, Xanadu, XtalPi
(Full list of 75+ companies captured in the market landscape analysis of the report)

Customization Scope

15% Free Customization Option (equivalent to 5 Analyst working days)
Excel Data Packs (Complimentary) Market Landscape Analysis, Company Competitiveness Analysis, Grant Analysis, Partnership and Collaboration Analysis, Market Forecast and Opportunity Analysis

 

The image highlights competitiveness amongst the quantum computing companies. In pursuit of gaining a competitive edge, manufacturers claim to be steadily expanding their existing capabilities in order to enhance their service portfolio related to quantum computing This image shows the high level of interest from government organization who are supporting quantum computing in drug discovery. Grants worth over USD 70 million have been awarded to various organizations that have actively undertaken R&D efforts to evaluate the potential of quantum computing in drug discovery The infographic highlights various partnerships that have been forged amongst quantum computing service providers either for quantum computing hardware or for quantum computing software. A considerable increase in the partnership activity has been witnessed in the past few years; close to 50% of the collaborations were inked by firms based in the same region

The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the report includes:

  • An executive summary of the insights captured during our research. It offers a high-level view on the current state of quantum computing in drug discovery market and its likely evolution in the short to mid and long term.
  • A general overview of quantum computing in drug discovery , along with information on its types and applications across various industries. It also highlights the applications of quantum computing, specifically related to drug discovery. Further, the chapter features a discussion on the challenges, key growth drivers, and future perspectives.
  • A detailed assessment of the overall market landscape of quantum computing software companies, based on several relevant parameters, including year of establishment, company size (in terms of number of employees), location of headquarters, business capabilities (platform / software, quantum as a service, drug discovery service and in-house pipeline), platform capabilities (drug discovery, drug design, supply chain management and drug development(clinical trials)), type of drug discovery service(s) offered (target discovery / identification,  target validation / selection, hit generation / identification / discovery, hit to lead / hit expansion / target to lead / lead identification / select lead series and lead optimization), type of molecule(s) supported (small molecules and large molecules), compatible computational approaches (artificial intelligence and cloud computing), end user(s) (pharmaceutical companies, contract research organizations and academic / research institutes) and therapeutic area(s) (cardiovascular disorders, infectious diseases, neurological disorders , oncological disorders and others)  
  • A detailed competitiveness analysis of quantum computing software companies based on company strength (in terms of years of experience), portfolio strength (in terms of type of drug discovery services offered, type of molecule(s) supported, type of computational approaches and type of end-user(s)), and portfolio diversity (in terms of business capabilities).
  • Elaborate profiles of quantum computing software companies. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.
  • A detailed assessment of the overall market landscape of quantum computing hardware companies, based on several parameters including year of establishment, company size (in terms of number of employees), location of headquarters, type of offering(s) (hardware as a service and hardware for purchase), data storage on cloud and compatible computational approaches (artificial intelligence and cloud computing)
  • Detailed profiles of quantum computing hardware companies. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.
  • A detailed review of over 170 academic grants focused on quantum computing in drug discovery, based on several relevant parameters, such as year of grants awarded, amount awarded, support period, type of study section, administering institute center, type of grant, activity code, funding mechanism and amount granted, funding institute and support period, prominent program officers (by number of grants), location of recipient organizations, popular recipient organizations, organization type and amount granted to popular recipient.
  • A detailed analysis of recent partnerships inked between stakeholders engaged in the quantum computing market, since 2017, based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships), and regional distribution of partnership activity in this domain.  
  • Quantum computing use cases highlighting the applications of quantum computing across various industries, such as chemical industry, cybersecurity, financial modeling, space sciences, oil and gas industry and weather forecasting, and its likely evolution in the foreseen future.
  • A qualitative analysis, highlighting the five competitive forces prevalent in quantum computing market supporting drug discovery, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute product and rivalry among existing competitors.
  • A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this industry to help unlock an uncontested market, featuring thirteen strategic tools that can help software companies to shift towards a blue ocean strategic market.

One of the key objectives of the market report was to estimate the current market size, opportunity and future growth potential of quantum computing market in drug discovery over the forecast period. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as drug discovery services offered (target identification / validation, hit generation / lead identification and lead optimization), therapeutic area (cardiovascular disorders, CNS disorders, dermatological disorders, endocrine disorders, gastrointestinal disorders, immunological disorders, infectious diseases, musculoskeletal disorders, oncological disorders,  respiratory disorders and others), and key geographical regions ((North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.

The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain. The market report features detailed transcripts of interviews held with the industry stakeholders.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

The image provides an insightful blue ocean stragey for quantum computing companies. Based on the pioneer-migrator-settler map, we have classified the software providers into different categories; a selection of pioneers is expected to provide valuable offerings to lead the market in the longer term The infographic highlights the quantum computing market size. We expect the market to grow at an annualized rate of 14% in the coming decade; the opportunity is likely to be well distributed across types of drug discovery services, therapeutic areas and key geographical regions  

Frequently Asked Questions

Question 1: What is quantum computing?

Answer: Quantum computing is a process that uses laws of quantum mechanics to solve large and complex problems in a short span as compared to the computer aided drug discovery.

Question 2: How can quantum computing help drug discovery?

Answer: The predictive power of quantum computing has proven to reduce the complexity, cost and time investment in the overall drug discovery process by allowing researchers to bypass the random screening of billions of molecules in a short span of time.

Question 3: Which part of drug discovery life cycle can quantum computing impact the most?

Answer: Lead optimization will be most influenced by quantum computing because of the role of quantum technology in modelling of molecular structures and evaluating the interactions of drug with its target.

Question 4: What is the quantum computing market size for application in drug discovery?

Answer: The global quantum computing market in drug discovery is estimated to be USD 411 million in 2022.

Question 5: What is the growth rate of quantum computing market focusing on drug discovery?

Answer: The global quantum computing market focusing on drug discovery is expected to grow at an annualized rate of 13.6% from 2023 to 2035.

Question 6: Which region is likely to hold the largest share in the quantum computing market focused on drug discovery?

Answer: North America is anticipated to capture the highest market share by 2035. In addition, the market in Asia-Pacific is likely to grow at a relatively faster pace, during the forecast period.

Question 7: Which type of service providers are most likely to dominate the quantum computing market for drug discovery?

Answer: Currently, quantum computing software companies hold the largest share in the market; this is followed by quantum computing hardware companies.

Question 8: What kind of partnership models are most commonly being adopted by stakeholders engaged in this industry?

Answer: Research and development agreements emerged as the most popular type of partnership model adopted by players engaged in offering quantum computing services for drug discovery. This is followed by platform utilization agreements.

Contents

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Overview of Quantum Computing in Drug Discovery
3.2. Drug Discovery and Development Timeline
3.3. Historical Evolution of Computational Drug Discovery Approaches
3.4. Classification of Quantum Computing Approaches
3.5. Applications of Quantum Computing in Drug Discovery Process
3.6. Advantages of Quantum Computing in Drug Discovery
3.7. Challenges Associated with Quantum Computing in Drug Discovery
3.8. Future Perspectives

4. MARKET LANDSCAPE: SOFTWARE PROVIDERS
4.1. Quantum Computing Software Providers: Overall Market Landscape
4.1.1. Analysis by Year of Establishment
4.1.2. Analysis by Company Size
4.1.3. Analysis by Location of Headquarters
4.1.4. Analysis by Business Capabilities
4.1.5. Analysis by Platform Capabilities
4.1.6. Analysis by Type of Drug Discovery Service(s) Offered
4.1.7. Analysis by Type of Molecule(s) Supported
4.1.8. Analysis by Compatible Computational Approaches
4.1.9. Analysis by End User(s)
4.1.10. Analysis by Therapeutic Area(s)

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Methodology and Key Parameters
5.2 Scoring Criteria
5.3. Company Competitiveness Analysis: Players based in North America (Peer Group I)
5.4. Company Competitiveness Analysis: Players based in Europe (Peer Group II)
5.5. Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World (Peer Group III)

6. COMPANY PROFILES: SOFTWARE PROVIDERS
6.1. Accenture
6.1.1. Company Overview
6.1.2. Financial Information
6.1.3. Service Portfolio
6.1.4. Recent Developments and Future Outlook

6.2. Atos
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Service Portfolio
6.2.4. Recent Developments and Future Outlook

6.3. Fujitsu
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Service Portfolio
6.3.4. Recent Developments and Future Outlook

6.4. Huawei
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Service Portfolio
6.4.4. Recent Developments and Future Outlook

6.5. Microsoft
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Service Portfolio
6.5.4. Recent Developments and Future Outlook

6.6. Xanadu
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. XtalPi
6.7.1. Company Overview
6.7.2. Service Portfolio
6.7.3. Recent Developments and Future Outlook

7. MARKET LANDSCAPE: HARDWARE PROVIDERS
7.1. Quantum Computing Hardware Providers: Overall Market Landscape
7.1.1. Analysis by Year of Establishment
7.1.2. Analysis by Company Size
7.1.3. Analysis by Region of Headquarters
7.1.4. Analysis by Location of Headquarters
7.1.5. Analysis by Type of Offering(s)
7.1.6. Analysis by Data Storage on Cloud
7.1.7. Analysis by Compatible Computational Approaches
7.1.8. Analysis by Type of Offering(s) and Compatible Computational Approaches

8. COMPANY PROFILES: HARDWARE PROVIDERS
8.1. Amazon Web Services
8.1.1. Company Overview
8.1.2. Financial Information
8.1.3. Service Portfolio
8.1.4. Recent Developments and Future Outlook

8.2. IBM
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Service Portfolio
8.2.4. Recent Developments and Future Outlook

8.3. Microsoft
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Service Portfolio
8.3.4. Recent Developments and Future Outlook

9. ACADEMIC GRANTS ANALYSIS
9.1. Analysis Methodology
9.2. Key Parameters
9.3. Analysis by Year of Grant
9.4. Analysis by Amount Awarded
9.5. Analysis by Support Period
9.6. Analysis by Study Section
9.7. Word Cloud Analysis: Emerging Focus Areas
9.8. Analysis by Administering Institute Center
9.9. Analysis by Type of Grant
9.10. Analysis by Activity Code
9.11. Analysis by Purpose of Grant
9.12. Analysis by Administering Institute Center and Support Period
9.13. Prominent Program Officers: Analysis by Number of Grants
9.14. Analysis by Location of Recipient Organizations
9.15. Analysis by Type of Organization
9.16. Popular Recipient Organizations: Analysis by Number of Grants
9.17. Popular Recipient Organizations: Analysis by Amount Awarded

10. PARTNERSHIPS AND COLLABORATIONS
10.1. Partnership Models
10.2. Quantum Computing in Drug Discovery, Drug Manufacturing and Other Services: Partnerships and Collaborations
10.3. Analysis by Year of Partnership
10.4. Analysis by Type of Partnership
10.5. Analysis by Year and Type of Partnership
10.6. Most Active Players: Analysis by Number of Partnerships
10.7. Word Cloud Analysis: Key Focus Areas
10.8. Analysis by Type of Continent
10.9. Analysis by Company Size and Type of Partnership
10.10. Local and Intercontinental Agreements
10.11. Intercontinental and Intracontinental Agreements

11. USE CASE STUDY
11.1. Overview of Quantum Computing
11.2. Applications of Quantum Computing Across Various Industries
11.3. Upcoming Trends in Quantum Computing
11.4. Future Perspectives

12. PORTER’S FIVE FORCES ANALYSIS
12.1. Methodology and Assumptions
12.2. Key Parameters
12.2.1. Threats of New Entrants
12.2.2. Bargaining Power of Buyers
12.2.3. Bargaining Power of Suppliers
12.2.4. Threats of Substitute Products
12.2.5. Rivalry among Existing Competitors

13. BLUE OCEAN STRATEGY: A STRATEGIC GUIDE FOR START-UPS TO ENTER INTO HIGHLY COMPETITIVE MARKET
13.1. Overview of Blue Ocean Strategy
13.1.1 Red Oceans
13.1.2 Blue Oceans
13.1.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
13.1.4. Quantum Computing in Drug Discovery Services Market: Blue Ocean Strategy and Shift Tools
13.1.4.1. Value Innovation
13.1.4.2. Strategy Canvas
13.1.4.3. Four Action Framework
13.1.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
13.1.4.5. Six Path Framework
13.1.4.6. Pioneer-Migrator-Settler (PMS) Map
13.1.4.7. Three Tiers of Non-customers
13.1.4.8. Sequence of Blue Ocean Strategy
13.1.4.9. Buyer Utility Map
13.1.4.10. The Price Corridor of the Mass
13.1.4.11. Four Hurdles to Strategy Execution
13.1.4.12. Tipping Point Leadership
13.1.4.13. Fair Process

14. MARKET SIZING AND OPPORTUNITY ANALYSIS
14.1. Forecast Methodology and Key Assumptions
14.2. Quantum Computing in Drug Discovery Services Market, 2023-2035
14.2.1. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Type of Drug Discovery Service Offered
14.2.1.1. Quantum Computing in Drug Discovery Services Market for Target Identification / Validation, 2023-2035
14.2.1.2. Quantum Computing in Drug Discovery Services Market for Hit Generation / Lead Identification, 2023-2035
14.2.1.3. Quantum Computing in Drug Discovery Services Market for Target Lead Optimization, 2023-2035

14.2.2. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Therapeutic Area
14.2.2.1. Quantum Computing in Drug Discovery Services Market for Cardiovascular Disorders, 2023-2035
14.2.2.2. Quantum Computing in Drug Discovery Services Market for CNS Disorders, 2023-2035
14.2.2.3. Quantum Computing in Drug Discovery Services Market for Dermatological Disorders, 2023-2035
14.2.2.4. Quantum Computing in Drug Discovery Services Market for Endocrine Disorders, 2023-2035
14.2.2.5. Quantum Computing in Drug Discovery Services Market for Gastrointestinal Disorders, 2023-2035
14.2.2.6. Quantum Computing in Drug Discovery Services Market for Immunological Disorders, 2023-2035
14.2.2.7. Quantum Computing in Drug Discovery Services Market for Infectious Diseases, 2023-2035
14.2.2.8. Quantum Computing in Drug Discovery Services Market for Musculoskeletal Disorders, 2023-2035
14.2.2.9. Quantum Computing in Drug Discovery Services Market for Oncological Disorders, 2023-2035
14.2.2.10. Quantum Computing in Drug Discovery Services Market for Respiratory Disorders, 2023-2035
14.2.2.11. Quantum Computing in Drug Discovery Services Market for Others, 2023-2035

14.2.3. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Key Geographical Regions
14.2.3.1. Quantum Computing in Drug Discovery Services Market in North America, 2023-2035
14.2.3.1.1. Quantum Computing in Drug Discovery Services Market in the US, 2023-2035
14.2.3.1.2. Quantum Computing in Drug Discovery Services Market in Canada, 2023-2035

14.2.3.2. Quantum Computing in Drug Discovery Services Market for Europe, 2023-2035
14.2.3.2.1. Quantum Computing in Drug Discovery Services Market in the UK, 2023-2035
14.2.3.2.2. Quantum Computing in Drug Discovery Services Market in France, 2023-2035
14.2.3.1.3. Quantum Computing in Drug Discovery Services Market in Germany, 2023-2035
14.2.3.1.4. Quantum Computing in Drug Discovery Services Market in Rest of the Europe, 2023-2035

14.2.3.3. Quantum Computing in Drug Discovery Services Market in Asia-Pacific, 2023-2035
14.2.3.3.1. Quantum Computing in Drug Discovery Services Market in China, 2023-2035
14.2.3.3.2. Quantum Computing in Drug Discovery Services Market in Japan, 2023-2035
14.2.3.3.3. Quantum Computing in Drug Discovery Services Market in Rest of Asia-Pacific, 2023-2035

14.2.3.4. Quantum Computing in Drug Discovery Services Market in Latin America, 2023-2035
14.2.3.5. Quantum Computing in Drug Discovery Services Market in Middle East and North Africa, 2023-2035

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 4.1 Quantum Computing Software Providers: Distribution by Year of Establishment
Figure 4.2 Quantum Computing Software Providers: Distribution by Company Size
Figure 4.3 Quantum Computing Software Providers: Distribution by Location of Headquarters
Figure 4.4 Quantum Computing Software Providers: Distribution by Business Capabilities
Figure 4.5 Quantum Computing Software Providers: Distribution by Platform Capabilities
Figure 4.6 Quantum Computing Software Providers: Distribution by Type of Drug Discovery Service(s) Offered
Figure 4.7 Quantum Computing Software Providers: Distribution by Type of Molecule(s) Supported
Figure 4.8 Quantum Computing Software Providers: Distribution by Compatible Computational Approaches
Figure 4.9 Quantum Computing Software Providers: Distribution by End user(s)
Figure 4.10 Quantum Computing Software Providers: Distribution by Therapeutic Area(s)
Figure 5.1 Company Competitiveness Analysis: Players based in North America (Peer Group I)
Figure 5.2 Company Competitiveness Analysis: Players based in Europe (Peer Group II)
Figure 5.3 Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World (Peer Group III)
Figure 6.1 Accenture: Revenues in USD Billion (FY 2017-FY 2022)
Figure 6.2 Atos: Revenues in EUR Billion (FY 2017- FY 9M 2022)
Figure 6.3 Fujitsu: Revenues in Yen Billion (FY 2017-FY H1 2022)
Figure 6.4 Huawei: Revenues in CNY Billion (FY 2017-FY 9M 2022)
Figure 6.5 Microsoft: Revenues in USD Billion (FY 2017-FY 2022)
Figure 7.1 Quantum Computing Hardware Providers: Distribution by Year of Establishment
Figure 7.2 Quantum Computing Hardware Providers: Distribution by Company Size
Figure 7.3 Quantum Computing Hardware Providers: Distribution by Region of Headquarters
Figure 7.4 Quantum Computing Hardware Providers: Distribution by Location of Headquarters
Figure 7.5 Quantum Computing Hardware Providers: Distribution by Type of Offering(s)
Figure 7.6 Quantum Computing Hardware Providers: Distribution by Data Storage on Cloud
Figure 7.6 Quantum Computing Hardware Providers: Distribution by Compatible Computational Approaches
Figure 7.7 Quantum Computing Hardware Providers: Distribution by Type of Offering(s) and Compatible Computational Approaches
Figure 8.1 Amazon Web Services: Revenues in USD Billion (FY 2017- FY 9M 2022)
Figure 8.2 Amazon Web Services: Service Portfolio
Figure 8.3 IBM: Revenues in USD Billion (FY 2017- FY 9M 2022)
Figure 8.4 IBM: Service Portfolio
Figure 8.5 Microsoft: Revenues in USD Billion (FY 2017- FY 2022)
Figure 8.6 Microsoft: Service Portfolio
Figure 9.1 Academic Grants Analysis: Distribution by Year of Grant
Figure 9.2 Academic Grants Analysis: Distribution by Amount Awarded
Figure 9.3 Academic Grants Analysis: Distribution by Support Period
Figure 9.4 Academic Grants Analysis: Distribution by Study Section
Figure 9.5 Word Cloud Analysis: Emerging Focus Areas
Figure 9.6 Academic Grants Analysis: Distribution by Administrating Institute Center
Figure 9.7 Academic Grants Analysis: Distribution by Type of Grant
Figure 9.8 Academic Grants Analysis: Distribution by Activity Code
Figure 9.9 Academic Grants Analysis: Distribution by Purpose of Grant
Figure 9.10 Academic Grants Analysis: Distribution by Funding Institute Center and Support Period
Figure 9.11 Prominent Program Officers: Distribution by Number of Grants
Figure 9.12 Academic Grants Analysis: Distribution by Location of Recipient Organizations
Figure 9.13 Academic Grants Analysis: Distribution by Type of Organization
Figure 9.14 Popular Recipient Organizations: Analysis by Number of Grants
Figure 9.15 Popular Recipient Organizations: Analysis by Amount Awarded
Figure 10.1 Partnerships and Collaborations: Cumulative Year-wise Trend
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Most Active Players: Distribution by Number of Partnerships
Figure 10.5 Word Cloud Analysis: Emerging Focus Areas
Figure 10.6 Partnerships and Collaborations: Distribution by Type of Continent
Figure 10.7 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Figure 10.8 Partnerships and Collaborations: Local and International Agreements
Figure 10.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.10 Partnerships and Collaborations: Key Value Drivers
Figure 12.1 Porter’s Five Forces: Key Parameters
Figure 12.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 13.1 Blue Ocean Strategy: Strategy Canvas
Figure 13.2 Blue Ocean Strategy: Pioneer-Migrator-Settler (PMS) Map
Figure 14.1 Quantum Computing in Drug Discovery Services Market, 2023-2035 (USD Million)
Figure 14.2 Quantum Computing in Drug Discovery Services Market, 2023 and 2035: Distribution by Type of Drug Discovery Service Offered
Figure 14.3 Quantum Computing in Drug Discovery Services Market for Target Identification / Validation, 2023-2035 (USD Million)
Figure 14.4 Quantum Computing in Drug Discovery Services Market for Hit Generation / Lead Identification, 2023-2035 (USD Million)
Figure 14.5 Quantum Computing in Drug Discovery Services Market for Target Lead Optimization, 2023-2035 (USD Million)
Figure 14.6 Quantum Computing in Drug Discovery Services Market, 2023 and 2035: Distribution by Therapeutic Area
Figure 14.7 Quantum Computing in Drug Discovery Services Market for Cardiovascular Disorders, 2023-2035 (USD Million)
Figure 14.8 Quantum Computing in Drug Discovery Services Market for CNS Disorders, 2023-2035 (USD Million)
Figure 14.9 Quantum Computing in Drug Discovery Services Market for Dermatological Disorders, 2023-2035 (USD Million)
Figure 14.10 Quantum Computing in Drug Discovery Services Market for Endocrine Disorders, 2023-2035 (USD Million)
Figure 14.11 Quantum Computing in Drug Discovery Services Market for Gastrointestinal Disorders, 2023-2035 (USD Million)
Figure 14.12 Quantum Computing in Drug Discovery Services Market for Immunological Disorders, 2023-2035 (USD Million)
Figure 14.13 Quantum Computing in Drug Discovery Services Market for Infectious Diseases, 2023-2035 (USD Million)
Figure 14.14 Quantum Computing in Drug Discovery Services Market for Musculoskeletal Disorders, 2023-2035 (USD Million)
Figure 14.15 Quantum Computing in Drug Discovery Services Market for Oncological Disorders, 2023-2035 (USD Million)
Figure 14.16 Quantum Computing in Drug Discovery Services Market for Respiratory Disorders, 2023-2035 (USD Million)
Figure 14.17 Quantum Computing in Drug Discovery Services Market for Others, 2023-2035 (USD Million)
Figure 14.18 Quantum Computing in Drug Discovery Services Market, 2023 and 2035: Distribution by Key Geographical Regions
Figure 14.19 Quantum Computing in Drug Discovery Services Market in North America, 2023-2035 (USD Million)
Figure 14.20 Quantum Computing in Drug Discovery Services Market in the US, 2023-2035 (USD Million)
Figure 14.21 Quantum Computing in Drug Discovery Services Market in Canada, 2023-2035 (USD Million)
Figure 14.22 Quantum Computing in Drug Discovery Services Market for Europe, 2023-2035 (USD Million)
Figure 14.23 Quantum Computing in Drug Discovery Services Market in the UK, 2023-2035 (USD Million)
Figure 14.24 Quantum Computing in Drug Discovery Services Market in France, 2023-2035 (USD Million)
Figure 14.25 Quantum Computing in Drug Discovery Services Market in Germany, 2023-2035 (USD Million)
Figure 14.26 Quantum Computing in Drug Discovery Services Market in Rest of the Europe, 2023-2035 (USD Million)
Figure 14.27 Quantum Computing in Drug Discovery Services Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 14.28 Quantum Computing in Drug Discovery Services Market in China, 2023-2035 (USD Million)
Figure 14.29 Quantum Computing in Drug Discovery Services Market in Japan, 2023-2035 (USD Million)
Figure 14.30 Quantum Computing in Drug Discovery Services Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Figure 14.31 Quantum Computing in Drug Discovery Services Market in Latin America, 2023-2035 (USD Million)
Figure 14.32 Quantum Computing in Drug Discovery Services Market in Middle East and North Africa, 2023-2035 (USD Million)

List Of Tables

Table 4.1 List of Quantum Computing Software Providers
Table 6.1 Accenture: Service Portfolio
Table 6.2 Accenture: Recent Developments and Future Outlook
Table 6.3 Atos: Service Portfolio
Table 6.4 Atos: Recent Developments and Future Outlook
Table 6.5 Fujitsu: Service Portfolio
Table 6.6 Fujitsu: Recent Developments and Future Outlook
Table 6.7 Huawei: Service Portfolio
Table 6.8 Huawei: Recent Developments and Future Outlook
Table 6.9 Microsoft: Service Portfolio
Table 6.10 Microsoft: Recent Developments and Future Outlook
Table 6.11 Xanadu: Service Portfolio
Table 6.12 Xanadu: Recent Developments and Future Outlook
Table 6.13 XtalPi: Service Portfolio
Table 6.14 XtalPi: Recent Developments and Future Outlook
Table 7.1 List of Quantum Computing Hardware Providers
Table 8.1 Amazon Web Services: Recent Developments and Future Outlook
Table 8.2 IBM: Recent Developments and Future Outlook
Table 8.3 Microsoft: Recent Developments and Future Outlook
Table 10.1 Quantum Computing in Drug Discovery Services: List of Partnerships and Collaborations
Table 16.1 Quantum Computing Software Providers: Distribution by Year of Establishment
Table 16.2 Quantum Computing Software Providers: Distribution by Company Size
Table 16.3 Quantum Computing Software Providers: Distribution by Location of Headquarters
Table 16.4 Quantum Computing Software Providers: Distribution by Business Capabilities
Table 16.5 Quantum Computing Software Providers: Distribution by Platform Capabilities
Table 16.6 Quantum Computing Software Providers: Distribution by Type of Drug Discovery Service(s) Offered
Table 16.7 Quantum Computing Software Providers: Distribution by Type of Molecule(s) Supported
Table 16.8 Quantum Computing Software Providers: Distribution by Type Compatible Computational Approaches
Table 16.9 Quantum Computing Software Providers: Distribution by End user(s)
Table 16.10 Quantum Computing Software Providers: Distribution by Therapeutic Area(s)
Table 16.11 Accenture: Revenues in USD Billion (FY 2017-FY 2022)
Table 16.12 Atos: Revenues in EUR Billion (FY 2017-FY 9M 2022)
Table 16.13 Fujitsu: Revenues in Yen Billion (FY 2017-FY H1 2022)
Table 16.14 Huawei: Revenues in CNY Billion (FY 2017-FY 9M 2022)
Table 16.15 Microsoft: Revenues in USD Billion (FY 2017-FY 2022)
Table 16.16 Quantum Computing Hardware Providers: Distribution by Year of Establishment
Table 16.17 Quantum Computing Hardware Providers: Distribution by Company Size
Table 16.18 Quantum Computing Hardware Providers: Distribution by Region of Headquarters
Table 16.19 Quantum Computing Hardware Providers: Distribution by Location of Headquarters
Table 16.20 Quantum Computing Hardware Providers: Distribution by Type of Offering(s)
Table 16.21 Quantum Computing Hardware Providers: Distribution by Data Storage on Cloud
Table 16.22 Quantum Computing Hardware Providers: Distribution by Compatible Computational Approaches
Table 16.23 Quantum Computing Hardware Providers: Distribution by Type of offering(s) and Compatible Computational Approaches
Table 16.24 Amazon Web Services: Revenues in USD Billion (FY 2017- FY 9M 2022)
Table 16.25 IBM: Revenues in USD Billion (FY 2017- FY 9M 2022)
Table 16.26 Microsoft: Revenues in USD Billion (FY 2017-FY 2022)
Table 16.27 Academic Grants Analysis: Distribution by Year of Grant
Table 16.28 Academic Grants Analysis: Distribution by Amount Awarded
Table 16.29 Academic Grants Analysis: Distribution by Support Period
Table 16.30 Academic Grants Analysis: Distribution by Study Section
Table 16.31 Academic Grants Analysis: Distribution by Administrating Institute Center
Table 16.32 Academic Grants Analysis: Distribution by Type of Grant
Table 16.33 Academic Grants Analysis: Distribution by Activity Code
Table 16.34 Academic Grants Analysis: Distribution by Purpose of Grant
Table 16.35 Academic Grants Analysis: Distribution by Administering Institute Center and Support Period
Table 16.36 Prominent Program Officers: Distribution by Number of Grants
Table 16.37 Academic Grants Analysis: Distribution by Location of Organizations
Table 16.38 Academic Grants Analysis: Distribution by Type of Organization
Table 16.39 Popular Recipient Organizations: Analysis by Number of Grants
Table 16.40 Popular Recipient Organizations: Analysis by Amount Awarded
Table 16.41 Partnerships and Collaborations: Distribution by Year
Table 16.42 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.43 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 16.44 Most Active Players: Distribution by Number of Partnerships
Table 16.45 Partnerships and Collaborations: Distribution by Type of Continent
Table 16.46 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Table 16.47 Partnerships and Collaborations: Local and International Agreements
Table 16.48 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.49 Quantum Computing in Drug Discovery Services Market, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.50 Quantum Computing in Drug Discovery Services Market, 2023 and 2035: Distribution by Type of Drug Discovery Service Offered
Table 16.51 Quantum Computing in Drug Discovery Services Market for Target Identification / Validation, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.52 Quantum Computing in Drug Discovery Services Market for Hit Generation / Lead Identification, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.53 Quantum Computing in Drug Discovery Services Market for Target Lead Optimization, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.54 Quantum Computing in Drug Discovery Services Market, 2023 and 2035: Distribution by Therapeutic Area
Table 16.55 Quantum Computing in Drug Discovery Services Market for Cardiovascular Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.56 Quantum Computing in Drug Discovery Services Market for CNS Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.57 Quantum Computing in Drug Discovery Services Market for Dermatological Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.58 Quantum Computing in Drug Discovery Services Market for Endocrine Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.59 Quantum Computing in Drug Discovery Services Market for Gastrointestinal Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.60 Quantum Computing in Drug Discovery Services Market for Immunological Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.61 Quantum Computing in Drug Discovery Services Market for Infectious Diseases, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.62 Quantum Computing in Drug Discovery Services Market for Musculoskeletal Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.63 Quantum Computing in Drug Discovery Services Market for Oncological Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.64 Quantum Computing in Drug Discovery Services Market for Respiratory Disorders, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.65 Quantum Computing in Drug Discovery Services Market for Others, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.66 Quantum Computing in Drug Discovery Services Market, 2023 and 2035: Distribution by Key Geographical Regions
Table 16.67 Quantum Computing in Drug Discovery Services Market in North America, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.68 Quantum Computing in Drug Discovery Services Market in the US, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.69 Quantum Computing in Drug Discovery Services Market in Canada, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.70 Quantum Computing in Drug Discovery Services Market for Europe, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.71 Quantum Computing in Drug Discovery Services Market in the UK, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.72 Quantum Computing in Drug Discovery Services Market in France, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.73 Quantum Computing in Drug Discovery Services Market in Germany, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.74 Quantum Computing in Drug Discovery Services Market in Rest of the Europe, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.75 Quantum Computing in Drug Discovery Services Market in Asia-Pacific, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.76 Quantum Computing in Drug Discovery Services Market in China, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.77 Quantum Computing in Drug Discovery Services Market in Japan, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.78 Quantum Computing in Drug Discovery Services Market in Rest of Asia-Pacific, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.79 Quantum Computing in Drug Discovery Services Market in Latin America, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)
Table 16.80 Quantum Computing in Drug Discovery Services Market in Middle East and North Africa, 2023-2035: Scenario I, Scenario II and Scenario III (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. 1QBit
  2. Accenture
  3. Albert Einstein College of Medicine
  4. Algorithmiq
  5. Alibaba 
  6. Aliro Quantum
  7. Allesh Biosciences Lab
  8. Alzheimer's Research UK University College London Drug Discovery Institute
  9. Amazon Web Services
  10. Amgen
  11. Anyon Systems
  12. ApexQubit
  13. Aqemia
  14. Astex Pharmaceuticals
  15. AstraZeneca
  16. Atos
  17. Auransa
  18. Aurora Fine Chemicals
  19. Automatski
  20. Biogen 
  21. Bleximo
  22. Boehringer Ingelheim
  23. Brigham and Women’s Hospital
  24. C4X Discovery Holdings
  25. Cambridge Quantum
  26. ChemAlive
  27. Cineca
  28. Cisco
  29. Cleveland Clinic 
  30. Cloud Pharmaceuticals 
  31. Conifer Point (Acquired by Lodo Therapeutics) 
  32. CreativeQuantum
  33. Crown Biosciences International (Acquired by JSR Life Sciences)
  34. Denovicon Therapeutics 
  35. D-wave 
  36. DXC Technology
  37. Entropica Labs 
  38. Envisagenics 
  39. FAR Biotech
  40. Fujitsu
  41. Good Chemistry 
  42. Google
  43. GTN
  44. Hafnium Labs
  45. Hewlett Packard Enterprise (HPE)
  46. Hypertrust Patient Data Care (HPDC)
  47. Honeywell
  48. Hybrid Quantum Architectures and Networks
  49. IBM 
  50. Iktos
  51. Indian Institute of Technology, Madras
  52. Infosys
  53. IonQ
  54. IQM
  55. Janssen Pharmaceuticals
  56. Kuano
  57. Kynogen
  58. Menten AI
  59. Ministry of Electronics and Information Technology
  60. Molecular Quantum Solutions
  61. Multiverse
  62. National Heart, Lungs and Blood Institute (NHLBI)
  63. National Institute of Health
  64. Netramark (Acquired by Nurosene Health)
  65. NVIDIA 
  66. Osaka University
  67. OVHcloud  
  68. Oxford Quantum Circuits (OQC)
  69. Pacific Northwest National Laboratory (PNNL)
  70. PASQAL
  71. Pfizer
  72. Pharmacelera
  73. PharmCADD 
  74. PhoreMost 
  75. PiDust
  76. Polaris Quantum Biotech
  77. Profacgen
  78. ProteinQure
  79. QC Ware
  80. QpiAI
  81. QRDLab
  82. QSimulate
  83. Qu&Co
  84. Quantinuum
  85. Quantum Brilliance
  86. Qubit Pharmaceuticals
  87. Quantronics Laboratory (QuLab)
  88. Qunova Computing
  89. Rescale
  90. Rigetti Computing
  91. RIKEN
  92. Riverlane
  93. Roche
  94. Roivant Discovery
  95. Sanofi
  96. SAP
  97. SEEQC 
  98. Servier
  99. Siemens 
  100. SpinQ
  101. StationQ (Subsidiary of Microsoft
  102. Tata Consultancy Services
  103. Terra Quantum
  104. Texas A&M AgriLife Research
  105. Toshiba
  106. UCL Quantum Science and Technology Institute
  107. University of Bristol Quantum Information Institute
  108. University of California 
  109. University of Chicago
  110. University of Illinois
  111. University of North Carolina System (UNC)
  112. University of Notre Dame
  113. University of Ottawa
  114. Xanadu
  115. XtalPi
  116. Zapata Computing

Source 1: https://ftloscience.com/process-costs-drug-development/
Source 2: http://phrma-docs.phrma.org/sites/default/files/pdf/rd_brochure_022307.pdf

PRICING DETAILS

USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

This site uses cookies for better browsing experience  Accept

Copyright © 2023 Roots Analysis. All Rights Reserved.